Cancer Gene Therapy

Genes Transform Inactive Pro-Drug into Pancreatic Cancer Killer

Published in Cancer Weekly, November 6th, 1995

Two genes that may influence the progression of pancreatic cancer have been discovered by surgical researchers from the Medical University of South Carolina, Charleston.

The genes most likely are not the only genetic elements that play a role in the development of pancreatic cancer. However, both genes have not been identified before in any other capacity and they are found to be over-expressed in tissue samples of pancreatic cancer but not in corresponding normal tissue. This discovery was reported by Paul L. Baron, M.D., FACS, assistant professor of surgery, Medical University of South Carolina during the 1995 Clinical Congress of the American College of Surgeons,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-11-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry